Daiichi Sankyo and its 15.000 employees in more than 20 countries are dedicated to the creation and supply of innovative pharmaceutical products. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group’s 2025 vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology. Our European headquarters are in Munich, Germany and we have affiliates in 13 European countries including Denmark, where Copenhagen acts as the Nordic headquarter.

Our strong oncology pipeline offers the great potential for consistent growth. Based on our ADC platform, we aim to offer innovative treatment concepts to patients with breast, non-small cell lung, colorectal and gastric cancer.

For the growing Oncology unit in our German organization Daiichi Sankyo Deutschland GmbH we are seeking highly qualified candidates to fill the position:

Key Account Manager Oncology (m/f/x)

Area: Köln, Bonn, Siegen

The Position:
The Key Account Manager Oncology works as part of the Daiichi Sankyo German oncology team within the local cross-functional territorial account team (TAT). She/he is expected to develop and execute territory-specific strategic account plans in close collaboration with the local cross-functional team to prepare for and execute a successful launch of Daiichi’s Oncology pipeline with trastuzumab deruxtecan as the first molecule to be launched in metastatic breast cancer.

In the defined region, the KAM Oncology will be responsible for the business results as well as ensuring its growth in alignment with the company strategic plan. She/he will actively collaborate within the TAT team to drive extensive engagement of KOL's and other key external stakeholders to create a receptive environment for DS Oncology assets and achieve the agreed sales targets. She/he will report directly to the First Line Sales Manager Oncology of the area.